Pfizer Colleagues Raise Over €425k for Irish Cancer Society

 Pfizer colleagues and friends across Ireland, including those from Ringaskiddy, have raised an impressive €425,355 for the Irish Cancer Society through their extensive, colleague-led fundraising efforts as part of the 2025 Pfizer Move for Cancer initiative.

The Move for Cancer initiative encompassed a variety of activities at Pfizer sites nationwide, such as runs, walks, swimathons, sports competitions, music gigs, and bake sales. These events aimed to raise awareness of cancer's impact on patients and their loved ones, and to generate much-needed funds for the Irish Cancer Society. The initiative culminated in the 2025 Pfizer Cycle, where 250 colleagues and friends cycled nearly 300km from Grange Castle, Co. Dublin, to Newbridge, Co. Kildare, and onto Ringaskiddy, Co. Cork, pedaling with a purpose in the name of cancer.

Averil Power from The Irish Cancer Society expressed profound gratitude at the presentation, stating, "We are so grateful to Pfizer in Ireland and its employees for their unwavering support and ongoing generosity. One in two of us will hear the words ‘You’ve got cancer’ in our lifetimes. There isn’t a family in Ireland that hasn’t felt the impact of a cancer diagnosis. Pfizer Ireland’s incredible “Move for Cancer” initiative helps ensure cancer patients and their families have access to vital free services and supports like counselling, transport to treatment and Night Nursing. Your generous donations will also fund ground-breaking cancer research, bringing us closer to our vision of a future where no one dies from the disease. None of this vital work would be possible without you, we cannot thank you enough.”

Pfizer colleagues and friends today presented the Irish Cancer Society with a cheque for over €425k following extensive colleague-led fundraising efforts as part of the 2025 Pfizer Move for Cancer initiative – including runs, walks, swimathons, sport competitions, music gigs, and bake sales – at Pfizer Ringaskiddy and sites across Ireland, aimed at raising awareness of the impact of cancer on patients and their loved ones. Pictured were (L-R): Pfizer’s John Sourke, VP, Sterile Injectables and Biotech Operations, who led the initiative with Ringaskiddy colleague Holly Lehane,  Averil Power, CEO of the Irish Cancer Society, and Tara Leigh O’Connor, also from Ringaskiddy.  Pic: Conor McCabe Photography.

John Sourke, VP, Sterile Injectables and Biotech Operations, also addressed the event, highlighting the personal significance of the initiative: "Cancer is a devastating disease that touches far too many lives, so this initiative is a deeply personal one to many of those involved. The roots of ‘Move for Cancer’ trace back to 2019, when Liam Ryan, a Pfizer colleague who passed away from cancer, envisioned a cycle event to raise money in support of The Irish Cancer Society’s programming. His legacy has lived on in every kilometer cycled and euro raised since our first event. 2025 is the fourth year of the cycle and this year we have raised almost as much as the three previous years combined so we are incredibly proud to be able to hand over such a significant sum today, bringing the total raised since the first Pfizer Cycle to €871,806."

Sourke concluded by extending his appreciation: “A huge thank you to all those who took part and helped us to reach this goal to improve the lives of cancer patients and their families across Ireland. Cancer is a formidable challenge, but by working together, we can outpace, outsmart, and outmanoeuvre this disease.”

For more information and highlights from Pfizer Move for Cancer, please visit: 2025 Pfizer Move for Cancer.